Orexo is for the third time shortlisted for the Annual Scrip Awards, chosen by a judging panel of 19 industry experts.
Together with Amgen, Merck, ProStrakan, AstraZeneca, GSK and others Orexo's CEO Torbjörn Bjerke and EVP/CFO Robin Wright will attend the ceremony on 4 November in London, where the winners will be announced. This year is Orexo shortlisted for categories Biotech Company of the Year, Best Partnership Alliance and Executive of the Year.
For more info visit www.scripawards.com or follow the link "The Scrip Awards Shortlist 2010".